KCM
GILD icon

Kendall Capital Management’s Gilead Sciences GILD Stock Holding History

Kendall Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Sell
8,362
-205
-2% -$27K 0.18% 128
2026
Q1 		$1.19M Sell
8,567
-85
-1% -$11.9K 0.24% 107
2025
Q4 		$1.06M Sell
8,652
-260
-3% -$31.6K 0.22% 111
2025
Q3 		$989K Buy
8,912
+90
+1% +$10.2K 0.22% 110
2025
Q2 		$978K Buy
8,822
+105
+1% +$11.2K 0.26% 99
2025
Q1 		$977K Buy
8,717
+25
+0.3% +$2.58K 0.29% 94
2024
Q4 		$803K Buy
8,692
+310
+4% +$27.9K 0.23% 112
2024
Q3 		$703K Buy
8,382
+1,065
+15% +$81.3K 0.22% 124
2024
Q2 		$502K Buy
7,317
+3,705
+103% +$247K 0.17% 141
2024
Q1 		$265K Buy
3,612
+25
+0.7% +$1.92K 0.09% 187
2023
Q4 		$291K Hold
3,587
– – 0.11% 171
2023
Q3 		$269K Buy
3,587
+895
+33% +$68.8K 0.12% 167
2023
Q2 		$207K Buy
+2,692
New +$215K 0.09% 190
2021
Q2 		– Sell
-3,125
Closed -$202K – 153
2021
Q1 		$202K Sell
3,125
-425
-12% -$27.4K 0.13% 139
2020
Q4 		$207K Sell
3,550
-175
-5% -$10.6K 0.15% 122
2020
Q3 		$235K Sell
3,725
-175
-4% -$12.1K 0.2% 108
2020
Q2 		$300K Sell
3,900
-15
-0.4% -$1.15K 0.29% 93
2020
Q1 		$293K Hold
3,915
– – 0.33% 82
2019
Q4 		$254K Sell
3,915
-198
-5% -$12.9K 0.2% 106
2019
Q3 		$261K Hold
4,113
– – 0.23% 98
2019
Q2 		$278K Sell
4,113
-52
-1% -$3.42K 0.25% 96
2019
Q1 		$271K Sell
4,165
-480
-10% -$31.9K 0.26% 94
2018
Q4 		$291K Sell
4,645
-1,701
-27% -$119K 0.3% 85
2018
Q3 		$490K Sell
6,346
-2,144
-25% -$162K 0.42% 71
2018
Q2 		$601K Sell
8,490
-3,127
-27% -$221K 0.53% 61
2018
Q1 		$876K Sell
11,617
-2,075
-15% -$165K 0.76% 43
2017
Q4 		$981K Buy
+13,692
New +$1.04M 0.87% 39

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kendall Capital Management's GILD Position: Q2 2026 in Review

Kendall Capital Management reduced its Gilead Sciences (GILD) stake by 2.4% in Q2 2026, selling an estimated $27K and leaving 8,362 shares worth $1.06M. The position accounts for 0.18% of the portfolio, ranked #128.

Kendall Capital Management first reported a position in GILD in Q4 2017 and has held it in 27 quarters since. The position peaked at $1.19M in Q1 2026. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Kendall Capital Management held 8,362 shares of Gilead Sciences worth $1.06M as of Q2 2026.
  • Kendall Capital Management sold 205 Gilead Sciences shares in Q2 2026, an estimated $27K.
  • Gilead Sciences made up 0.18% of Kendall Capital Management's portfolio in Q2 2026, its #128 holding.
  • Kendall Capital Management first reported a position in Gilead Sciences in Q4 2017 and has held it in 27 quarters since.
  • Kendall Capital Management's Gilead Sciences position peaked at $1.19M in Q1 2026.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Kendall Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.